Radiopharmaceutical firm Pentixapharm announced its acquisition of Glycotope’s target discovery business, including a portfolio of oncology antibodies, laboratories, and associated assets. Currently owned by the Eckert & Ziegler Group, Pentixapharm will soon become a separate company. The firm is developing treatments for diseases like CNS lymphoma and primary aldosteronism.
“Dance of the Hillary” and the Expanding Use of Malware in Regional Cyber Conflict
The Punjab Police’s cybercrime wing in India warns of a new malware strain potentially from Pakistan called “Dance of the Hillary”. This malware is designed
